drugset / Trial / NCT05072938
Clinical Trial to Compare Rebamipide/Nizatidine Combination Therapy With Nizatidine Monotherapy in Patients With Gastritis
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to compare the Efficacy and Safety of Rebamipide/Nizatidine Combination Therapy with Nizatidine Monotherapy in Patients with Gastritis
Timeline
- Start
- 2021-09-30
- Primary completion
- 2022-12-15
- Completion
- 2022-12-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Nizatidine | Small molecule | 150 mg | — |
| Subject | Rebamipide | Small molecule | — | — |